Denali Capital extends business combination deadline to Sep 11 via $180K Scilex note

Semnur Pharmaceuticals, Inc.

Deposited $15,036.74 into trust to extend deadline to Sep 11, 2024 from Aug 11.
Issued up to $180,000 convertible note to Scilex (SCLX); initial draw $15,036.74.
Note bears no interest, repayable upon business combination or liquidation; convertible at $10/share.
Remaining $164,963.26 available for future monthly extensions as needed.
If no business combination, note repaid only from non-trust funds or forfeited.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.